Results 51 to 60 of about 868 (155)

Intraprocedural C‐arm dual‐phase cone‐beam enhancement patterns correlate with tumor absorbed dose after radioembolization

Medical Physics, Volume 51, Issue 4, Page 3045-3052, April 2024.
Abstract Background Recent studies have shown a clear relationship between absorbed dose and tumor response to treatment after hepatic radioembolization. These findings help to create more personalized treatment planning and dosimetry. However, crucial to this goal is the ability to predict the dose distribution prior to treatment.
Remco Bastiaannet, MingDe Lin, Eric C. Frey, Hugo W. A. M. de Jong   +3 more
wiley   +1 more source

Intra-arterial treatment with 90Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital

, 2011
Purpose We report on our experience in terms of eligibility, safety, response and survival for treatment of hepatocellular carcinoma (HCC) with (90)Y microspheres. Secondly, we investigated the urinary excretion of (90)Y following treatment.
Mertens, Jeroen, Emiel Sturm, Defreyne, Luc, Peter Smeets, Roberto Troisi, STURM, EMIEL, Lambert, Bieke, Ruth Oltenfreiter, Oltenfreiter, Ruth, Bieke Lambert, Van Vlierberghe, Hans, Troisi, Roberto, Hans Van Vlierberghe, Jeroen Mertens, Smeets, Peter, Luc Defreyne   +15 more
core   +1 more source

Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma

, 2017
Intrahepatic cholangiocarcinoma (ICC) is a severe and rapidly progressive hepatic tumor. Surgery is often impracticable due to locally advanced presentation. On the other hand, chemotherapy has demonstrated only limited effectiveness.
Filippi, L, Bagni, O, Schillaci O., Cianni, R, Filippi L., Bagni O., Cianni R., Schillaci, O   +7 more
core   +2 more sources

Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review [PDF]

, 2016
Hepatocellular carcinoma is the most common primary liver cancer and it represents the majority of cancer-related deaths in the world. More than 70% of patients present at an advanced stage, beyond potentially curative options.
Alanis, Lourdes, Cho, Sung-Ki, Lee, Edward Wolfgang, Saab, Sammy   +3 more
core   +1 more source

Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France

, 2022
International audiencePrimary Objective: Recently, selective internal radiation therapy using yttrium-90 (Y90) glass microspheres (TheraSphere™) was approved for reimbursement by health authorities in France.
Tordo, Jeremie, Bailly, Clement, Becker, Stéphanie, Goupil, Jean, Manfredi, Sylvain, Patel, Binal, Bouvier, Antoine, de Baere, Thierry, Vicaut, Eric, Boucher, Eveline, Mastier, Charles, Mariano-Goulart, Denis, Somma, Claude, Edeline, Julien, Garin, Etienne, Sengel, Christian, Regnault, Helene, Rode, Agnes, Vibert, Eric, Blanc, Jean-Frederic, Sefrioui, David, Guiu, Boris, Pinaquy, Jean-Baptiste, Chevallier, Patrick   +23 more
core   +1 more source

Development of a Database for Storage and Analysis of Factors Affecting Treatment of Hepatocellular Carcinoma

, 2011
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine.Hepatocellular carcinoma (HCC) is the fifth most common solid tumor worldwide. There are 626,000
Mitropanopoulos, Meg
core   +5 more sources

Radial Dose Profile of a Y-90 Sphere

, 2018
This file contains the raw data of a radial dose profile of a sphere of Y-90 designed by Therasphere, obtained by Monte Carlo simulation with the code PENELOPE (2011).
Pérez-García, H (via Mendeley Data)
core   +1 more source

Clinical and dosimetric considerations for Y90 recommendations from an international multidisciplinary working group

, 2019
International audienceThe TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry.
Salem, Riad, Lam, Marnix, Chiesa, Carlo, Sze, Daniel, Padia, Siddharth A, Hamilton, Bonnie, Padia, Siddharth A., Fowers, Kirk, Bell, Jon, Kappadath, S. Cheenu, Kappadath, S Cheenu, Herman, Joseph, Leung, Thomas, Garin, Etienne, Portelance, Lorraine   +14 more
core   +1 more source

Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled microspheres.

, 2011
International audienceThe goal of this study was to assess the use of quantitative single-photon emission computed tomography/computed tomography (SPECT/CT) analysis for vascularized volume measurements in the use of the yttrium-90-radiolabeled ...
Marc Pracht, Clément, Bruno, Habiba Mesbah, Eveline Boucher, Pracht, Marc, Philippe Porée, Boucher, Eveline, Yan Rolland, Etienne Garin, Rolland, Yan, Valérie Ardisson, Laffont, Sophie, Ardisson, Valérie, Garin, Etienne, Porée, Philippe, Bruno Clement, Lenoir, Laurence, Sophie Laffont, Patrick Bourguet, Laurence Lenoir, Bourguet, Patrick, Mesbah, Habiba   +21 more
core   +1 more source

TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial [PDF]

, 2019
BACKGROUND: Colorectal cancer is one of the most common cancers and causes of cancer-related death. Up to approximately 70% of patients with metastatic colorectal cancer (mCRC) have metastases to the liver at initial diagnosis.
Benson Iii, AB, Cosgrove, D, Laframboise, C, Chauhan, N, Strosberg, JR, Salem, R, Lewandowski, RJ, Bukovcan, J, Master, F, Sharma, RA, Boucher, E, El-Rayes, B, Mulcahy, MF, Sze, DY   +13 more
core   +1 more source